Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 20Active not recruiting 5Terminated 3Not yet recruiting 3Completed 3Withdrawn 1Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 10Neoplasms 9Leukemia, Myeloid, Acute 9Glioblastoma 9Colorectal Neoplasms 8Neoplasm Metastasis 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Multiple Myeloma 5Hematologic Neoplasms 5Ovarian Neoplasms 4Glioma 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Sarcoma 3Melanoma 3Head and Neck Neoplasms 3Triple Negative Breast Neoplasms 2Solid Tumors 2Solid Tumor 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Neoplasm, Residual 2

Interventions

Azacitidine 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, T-Cell, Peripheral × 90 days × Clear all
NCT07388563 2026-05-08

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Suspended
20 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡